Ultrasound-promoted greener synthesis of novel trifurcate 3-substituted-chroman-2,4-dione derivatives and their drug-likeness evaluation

Molecules

Volumn 17, Issue 12, 2012, Pages 14146-14158

  Liang, Chengyuan ^a   Jiang, Hailong ^a   Zhou, Zhiguang ^a   Lei, Dong ^a   Xue, Yu ^a   Yao, Qizheng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chroman 2,4 diones; Coumarin; Edaravone; Green chemistry; Multicomponent reactions (MCRs); Ultrasonic irradiation

Indexed keywords

ALDEHYDE; ANTINEOPLASTIC AGENT; CHROMAN DERIVATIVE; CHROMONE DERIVATIVE; COUMARIN DERIVATIVE; DRUG DERIVATIVE; PHENAZONE; PHENYLMETHYLPYRAZOLONE; PYRAZOLONE; PYRAZOLONE DERIVATIVE; WATER;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; SOUND; SYNTHESIS;

ALDEHYDES; ANTINEOPLASTIC AGENTS; ANTIPYRINE; CHROMANS; CHROMONES; COUMARINS; MOLECULAR STRUCTURE; PYRAZOLONES; SOUND; WATER;

EID: 84871544926     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171214146     Document Type: Article

References (29)

1. Blaskovicova, M.; Gaplovsky, A.; Blasko, J. Synthesis and Photochemistry of 1-Iodocyclohexene: Influence of Ultrasound on Ionic vs. Radical Behaviour. Molecules 2007, 12, 188-193.
2. Doan, N.; Le, T.; Nguyen, H.; Hansen, P.; Duus, F. Ultrasound Assisted Synthesis of 5,9-Dimethylpentadecane and 5,9-Dimethylhexadecane- The Sex Pheromones of Leucoptera coffeella. Molecules 2007, 12, 2080-2088.
3. Xiao, L.; Liu, C.-J.; Li, Y.-P. Ultrasound Promoted Synthesis of Bis (substituted pyrazol-4-ylcarbonyl)-Substituted Thioureas. Molecules 2009, 14, 1423-1428.
4. Liu, C.-J.; Wang, J.-D. Ultrasound-Assisted Synthesis of Novel 4-(2-Phenyl-1,2,3-Triazol-4-yl)-3,4-Dihydropyrimidin-2(1H)-(Thio)ones Catalyzed by Sm(ClO4)3. Molecules 2010, 15, 2087-2095.
5. Wang, J.; Bai, X.; Xu, C.; Wang, Y.; Lin, W.; Zou, Y.; Shi, D. Ultrasound-Promoted One-Pot, Three-Component Synthesis of Spiro[indoline-3,1'- pyrazolo[1,2-b]phthalazine] Derivatives. Molecules 2012, 17, 8674-8686.
6. Gao, D.-M.; Ma, W.-L.; Li, T.-R.; Huang, L.-Z.; Du, Z.-T. An Improved Synthesis of 1,2-Diarylethanols under Conventional Heating and Ultrasound Irradiation. Molecules 2012, 17, 10708-10715.
7. Gomha, S.M.; Khalil, K.D. A Convenient Ultrasound-Promoted Synthesis of Some New Thiazole Derivatives Bearing a Coumarin Nucleus and Their Cytotoxic Activity. Molecules 2012, 17, 9335-9347.
8. Aggeler, P.M.; O'Reilly, R.A.; Leong, L.; Kowitz, P.E. Potentiation of anticoagulant effect of warfarin by phenylbutazone. N. Engl. J. Med. 1967, 276, 496-501.
9. O'Reilly, R.A.; Aggeler, P.M. Studies on coumarin anticoagulant drugs: Initiation of warfarin therapy without a loading dose. Circulation 1968, 38, 169-177.
10. Huang, L.; Yuan, X.; Yu, D.; Lee, K.; Ho Chen, C. Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives. Virology 2005, 332, 623-628.
11. Spino, C.; Dodier, M.; Sotheeswaran, S. Anti-HIV coumarins from Calophyllum seed oil. Bioorg. Med. Chem. Lett. 1998, 8, 3475-3478.
12. Baba, M.; Jin, Y.; Mizuno, A.; Suzuki, H.; Okada, Y.; Takasuka, N.; Tokuda, H.; Nishino, H.; Okuyama, T. Studies on Cancer Chemoprevention by Traditional Folk Medicines XXIV.- Inhibitory Effect of a Coumarin Derivative, 7-Isopentenyloxycoumarin, against Tumor-Promotion. Biol. Pharm. Bull. 2002, 25, 244-246.
13. Murakami, A.; Kuki, W.; Takahashi, Y.; Yonei, H.; Nakamura, Y.; Ohto, Y.; Ohigashi, H.; Koshimizu, K. Auraptene, A Citrus Coumarin, Inhibits 12-o-Tetradecanoylphorbol-13-Acetate-induced Tumor Promotion in ICR Mouse Skin, Possibly through Suppression of Superoxide Generation in Leukocytes. Cancer Sci. 1997, 88, 443-452.
14. Kelly, R.A.; Gelfand, J.A.; Pincus, S.H. Cutaneous necrosis caused by systemicallyadministered heparin. JAMA1981, 246, 1582-1583.
15. Stanchev, S.; Momekov, G.; Jensen, F.; Manolov, I. Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives. Eur . J. Med. Chem. 2008, 43, 694-706.
16. Chohan, Z.H.; Shaikh, A.U.; Rauf, A.; Supuran, C.T. Antibacterial, antifungal and cytotoxic properties of novel N-substituted sulfonamides from 4-hydroxycoumarin. J. Enzym. Inhib. Med. Chem. 2006, 21, 741-748.
17. Thaisrivongs, S.; Watenpaugh, K.D.; Howe, W.J.; Tomich, P.K.; Dolak, L.A.; Chong, K.T.; Tomich, C.S.C.; Tomasselli, A.G.; Turner, S.R. Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. J. Med. Chem. 1995, 38, 3624-3637.
18. Kostova, I. Synthetic and natural coumarins as cytotoxic agents. Curr. Med. Chem. 2005, 5, 29-46.
19. Dias, L.R.S.; Salvador, R.R.S. Pyrazole Carbohydrazide Derivatives of Pharmaceutical Interest. Pharmaceuticals 2012, 5, 317-324.
20. Wang, X.H.; Wang, X.K.; Liang, Y.J.; Shi, Z.; Zhang, J.Y.; Chen, L.M.; Fu, L.W. A cellbased screen for anticancer activity of 13 pyrazolone derivatives. Chin. J. Cancer 2010, 29, 980-987.
21. Chandrasekharan, N.; Dai, H.; Roos, K.; Evanson, N.K.; Tomsik, J.; Elton, T.S.; Simmons, D.L. COX-3, A cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, Structure, And expression. Proc. Nat. Acad. Sci. USA 2002, 99, 13926-13931.
22. Laporte, J.; Carne, X.; Vidal, X.; Moreno, V.; Juan, J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991, 337, 85-89.
23. Shichinohe, H.; Kuroda, S.; Yasuda, H.; Ishikawa, T.; Iwai, M.; Horiuchi, M.; Iwasaki, Y.: Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res. 2004, 1029, 200-206.
24. Toyoda, K.; Fujii, K.; Kamouchi, M.; Nakane, H.; Arihiro, S.; Okada, Y.; Ibayashi, S.; Iida, M. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J. Neurol. Sci. 2004, 221, 11-17.
25. Kokura, S.; Yoshida, N.; Sakamoto, N.; Ishikawa, T.; Takagi, T.; Higashihara, H.; Nakabe, N.; Handa, O.; Naito, Y.; Yoshikawa, T. The radical scavenger edaravone enhances the anti-tumor effects of CPT-11 in murine colon cancer by increasing apoptosis via inhibition of NF-κB. Cancer Lett. 2005, 229, 223-233.
26. Sueishi, K.; Mishima, K.; Makino, K.; Itoh, Y.; Tsuruya, K.; Hirakata, H.; Oishi, R. Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur. J. Pharmacol. 2002, 451, 203-208.
27. Iguchi, T.; Nishikawa, M.; Chang, B.J.; Muroya, O.; sato, E.F.; Nakatani, T.; Inoue, M. Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney. Free Radic. Res. 2004, 38, 333-341.
28. Hopkins, A.L.; Groom, C.R. The druggable genome. Nat. Rev. Drug Discov. 2002, 1, 727-730.
29. Lipinski, C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Method. 2000, 44, 235-249.